Efficacy News and Research

RSS
IsoRay third fiscal quarter sales increase 17%

IsoRay third fiscal quarter sales increase 17%

Journal of Burn Care & Research publishes Caldolor clinical study data in hospitalized patients

Journal of Burn Care & Research publishes Caldolor clinical study data in hospitalized patients

Australian TGA approves Biogen Idec's FAMPYRA to improve walking ability in patients with MS

Australian TGA approves Biogen Idec's FAMPYRA to improve walking ability in patients with MS

VAYA Pharma's Vayarin now available in South, North Carolina and Texas for children with ADHD

VAYA Pharma's Vayarin now available in South, North Carolina and Texas for children with ADHD

Techulon receives U.S. patent protection for Glycofect Discovery and Therapeutic Delivery Platform

Techulon receives U.S. patent protection for Glycofect Discovery and Therapeutic Delivery Platform

Otsuka Pharmaceutical reports OPC-34712 Phase 2 trial results in major depressive disorder

Otsuka Pharmaceutical reports OPC-34712 Phase 2 trial results in major depressive disorder

pSivida resubmits ILUVIEN NDA to FDA for diabetic macular edema treatment

pSivida resubmits ILUVIEN NDA to FDA for diabetic macular edema treatment

IVF causing multiple birth rates fall

IVF causing multiple birth rates fall

AMS signs research grant contract for six sites to evaluate vaginal prolapse repair techniques

AMS signs research grant contract for six sites to evaluate vaginal prolapse repair techniques

German doctors among first to treat ischemic stroke patients with new blood clot retrieval device

German doctors among first to treat ischemic stroke patients with new blood clot retrieval device

Bovie Medical first quarter revenues increase 10% to $6.2 million

Bovie Medical first quarter revenues increase 10% to $6.2 million

New clinical data affirms safety profile of PolyMedix's PMX-30063 in treatment of Staph infections

New clinical data affirms safety profile of PolyMedix's PMX-30063 in treatment of Staph infections

CrystalGenomics receives draft CSR for CG400549 Phase I MAD study in Staph infections

CrystalGenomics receives draft CSR for CG400549 Phase I MAD study in Staph infections

Sugar boosts effectiveness of first-line antibiotics against chronic bacterial infections

Sugar boosts effectiveness of first-line antibiotics against chronic bacterial infections

Researcher finds ultrasound as effective as CT scans for head and neck diagnoses

Researcher finds ultrasound as effective as CT scans for head and neck diagnoses

GSK, NanoBio initiate two NB-001 Phase 3 trials in cold sores

GSK, NanoBio initiate two NB-001 Phase 3 trials in cold sores

MHI team uses cryoablation to successfully treat atrial fibrillation

MHI team uses cryoablation to successfully treat atrial fibrillation

Naurex announces completion of $18 million Series A financing

Naurex announces completion of $18 million Series A financing

TSA, Psyadon Pharmaceuticals partner for ecopipam clinical trial in Tourette Syndrome

TSA, Psyadon Pharmaceuticals partner for ecopipam clinical trial in Tourette Syndrome

Pacira Pharmaceuticals reports net loss of $9.8 million for first quarter 2011

Pacira Pharmaceuticals reports net loss of $9.8 million for first quarter 2011

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.